Nebivolol Versus Bisoprolol Versus Carvedilol in Heart Failure

Centro Cardiologico Monzino60 enrolled

Overview

The investigators test the hypothesis that different beta-blockers had a different influence on chemoreceptor response and lung diffusion capacity. Both could influence exercise capacity in normoxic as well as hypoxic conditions.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Chronic Heart Failure

Interventions

carvedilolDRUG

bisoprololDRUG

NebivololDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Chronic heart failure patients in stable clinical condition Exclusion Criteria: * No comorbidity * NYHA class IV

Locations (1)

Centro Cardiologico Monzino, University of Milan

Milan, Italy

Outcomes

Primary Outcomes

exercise capacity

Time frame: two months

Secondary Outcomes

lung diffusion

Time frame: two months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.